| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | RGS17 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | SACM1L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | ATP6V1A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | RALBP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | PPP4R3B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | PRDX4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | P2RY8 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.08 |
| mRNA | CHD1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
